Flindr Therapeutics

Amsterdam, The Netherlands

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

$21.4M raised

Apr 2024

Series A

Biotechnology Health Care Therapeutics

Top Investors

V-Bio Ventures Qbic Fund Innovatiefonds Noord-Holland Johnson & Johnson Innovation Curie Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Flindr Therapeutics

How much funding has Flindr Therapeutics raised?

Flindr Therapeutics has raised $21.4M in total funding. The most recent round was Series A. The last funding was announced in April 2024.

Who are Flindr Therapeutics's investors?

Flindr Therapeutics's investors include V-Bio Ventures, Qbic Fund, Innovatiefonds Noord-Holland, Johnson & Johnson Innovation, Curie Capital.

Where is Flindr Therapeutics headquartered?

Flindr Therapeutics is headquartered in Amsterdam, The Netherlands.

What does Flindr Therapeutics do?

Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.

What stage is Flindr Therapeutics at?

Flindr Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2024.

MLA

"Flindr Therapeutics — Funding & Investors." VCBacked, April 24, 2024, https://www.vcbacked.co/company/flindr-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). Flindr Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/flindr-therapeutics

Wikipedia (cite web)

{{cite web |title=Flindr Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/flindr-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2024.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K